References
- InestrosaNCArenasEEmerging roles of Wnts in the adult nervous systemNat Rev Neurosci2010112778620010950
- van AmerongenRMikelsANusseRAlternative Wnt signaling is initiated by distinct receptorsSci Signal2008135re918765832
- GordonMDNusseRWnt signaling: multiple pathways, multiple receptors, and multiple transcription factorsJ Biol Chem200628132224292243316793760
- KikuchiAYamamotoHSatoAMatsumotoSNew insights into the mechanism of Wnt signaling pathway activationInt Rev Cell Mol Biol2011291217122017973
- AberleHBauerAStappertJKispertAKemlerRβ-Catenin is a target for the ubiquitin-proteasome pathwayEMBO J19971613379738049233789
- PatapoutianAReichardtLFRoles of Wnt proteins in neural development and maintenanceCurr Opin Neurobiol200010339239910851180
- CianiLSalinasPCWnts in the vertebrate nervous system: from patterning to neuronal connectivityNat Rev Neurosci20056535136215832199
- OlivaCAVargasJYInestrosaNCWnts in adult brain: from synaptic plasticity to cognitive deficienciesFront Cell Neurosci2013722424348327
- ToledoEMColombresMInestrosaNCWnt signaling in neuroprotection and stem cell differentiationProg Neurobiol200886328129618786602
- Le GrandJNGonzalez-CanoLPavlouMASchwambornJCNeural stem cells in Parkinson’s disease: a role for neurogenesis defects in onset and progressionCell Mol Life Sci201572477379725403878
- BerwickDCHarveyKThe importance of Wnt signalling for neurodegeneration in Parkinson’s diseaseBiochem Soc Trans20124051123112822988876
- YuanSShiYTangSJWnt signaling in the pathogenesis of multiple sclerosis-associated chronic painJ Neuroimmune Pharmacol20127490491322547300
- TrappBDNaveKAMultiple sclerosis: an immune or neurodegenerative disorder?Annu Rev Neurosci20083124726918558855
- GovermanJAutoimmune T cell responses in the central nervous systemNat Rev Immunol20099639340719444307
- WeberMSMengeTLehmann-HornKCurrent treatment strategies for multiple sclerosis: efficacy versus neurological adverse effectsCurr Pharm Des201218220921922229582
- WillsonTMLambertMHKliewerSAPeroxisome proliferator-activated receptor gamma and metabolic diseaseAnnu Rev Biochem20017034136711395411
- HenekaMTLandrethGEHullMDrug insight: effects mediated by peroxisome proliferator-activated receptor-γ in CNS disordersNat Clin Pract Neurol20073949650417805244
- LecarpentierYClaesVDuthoitGHebertJLCircadian rhythms, Wnt/β-catenin pathway and PPAR α/γ profiles in diseases with primary or secondary cardiac dysfunctionFront Physiol2014542925414671
- SabatinoLPancioneMVotinoCEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerWorld J Gastroenterol201420237137715124966585
- GiacoppoSGaluppoMMontautSAn overview on neuroprotective effects of isothiocyanates for the treatment of neurodegenerative diseasesFitoterapia2015106122126254971
- GaluppoMGiacoppoSDe NicolaGRAntiinflammatory activity of glucomoringin isothiocyanate in a mouse model of experimental autoimmune encephalomyelitisFitoterapia20149516017424685508
- BrunelliDTavecchioMFalcioniCThe isothiocyanate produced from glucomoringin inhibits NF-kB and reduces myeloma growth in nude mice in vivoBiochem Pharmacol20107981141114820006591
- MaldiniMMaksoudSANatellaFMoringa oleifera: study of phenolics and glucosinolates by mass spectrometryJ Mass Spectrom201449990091025230187
- Abdull RazisAFDe NicolaGRPagnottaEIoriRIoannidesC4-Methylsulfanyl-3-butenyl isothiocyanate derived from glucoraphasatin is a potent inducer of rat hepatic phase II enzymes and a potential chemopreventive agentArch Toxicol201286218319421960141
- Baasanjav-GerberCMonienBHMewisIIdentification of glucosinolate congeners able to form DNA adducts and to induce mutations upon activation by myrosinaseMol Nutr Food Res201155578379221213326
- BarillariJCervellatiRPaoliniMTatibouetARollinPIoriRIsolation of 4-methylthio-3-butenyl glucosinolate from Raphanus sativus sprouts (kaiware daikon) and its redox propertiesJ Agric Food Chem200553269890989616366671
- No authors listedEEC regulation 1864/90, enclosure VIIIOffic J Eur Commun1990L1702734
- GiacoppoSGaluppoMDe NicolaGRIoriRBramantiPMazzonE4(α-l-rhamnosyloxy)-benzyl isothiocyanate, a bioactive phytochemical that attenuates secondary damage in an experimental model of spinal cord injuryBioorg Med Chem2015231808825497964
- PessinaAThomasRMPalmieriSLuisiPLAn improved method for the purification of myrosinase and its physicochemical characterizationArch Biochem Biophys199028023833892369130
- GiacoppoSGaluppoMDe NicolaGRIoriRBramantiPMazzonETuscan black kale sprout extract bioactivated with myrosinase: a novel natural product for neuroprotection by inflammatory and oxidative response during cerebral ischemia/reperfusion injury in ratBMC Complement Altern Med20151539726545366
- GaluppoMGiacoppoSIoriRDe NicolaGRBramantiPMazzonEAdministration of 4-(α-L-rhamnosyloxy)-benzyl isothiocyanate delays disease phenotype in SOD1G93A rats: a transgenic model of amyotrophic lateral sclerosisBiomed Res Int2015201525941726075221
- PaschalidisNIqbalAJMaioneFModulation of experimental autoimmune encephalomyelitis by endogenous annexin A1J Neuroinflammation200963319912648
- RodriguesDHVilelaMCBarcelosLSPinhoVTeixeiraMMTeixeiraALAbsence of PI3Kγ leads to increased leukocyte apoptosis and diminished severity of experimental autoimmune encephalomyelitisJ Neuroimmunol20102221–2909420303183
- ConstantinescuCSFarooqiNO’BrienKGranBExperimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)Br J Pharmacol201116441079110621371012
- HuRHebbarVKimBRIn vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the ratJ Pharmacol Exp Ther2004310126327114988420
- Dinkova-KostovaATHoltzclawWDColeRNDirect evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidantsProc Natl Acad Sci U S A20029918119081191312193649
- NoseworthyJHLucchinettiCRodriguezMWeinshenkerBGMultiple sclerosisN Engl J Med20003431393895211006371
- MarchettiBPluchinoSWnt your brain be inflamed? Yes, it Wnt!Trends Mol Med201319314415623312954
- KimHWonSHwangDYDownregulation of Wnt/β-catenin signaling causes degeneration of hippocampal neurons in vivoNeurobiol Aging201132122316.e1e15
- HalleskogCMulderJDahlströmJWnt signaling in activated microglia is proinflammatoryGlia201159111913120967887
- L’EpiscopoFTiroloCTestaNReactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson’s diseaseNeurobiol Dis201141250852721056667
- XieCLiZZhangGXGuanYWnt signaling in remyelination in multiple sclerosis: friend or foe?Mol Neurobiol20144931117112524243343
- FancySPBaranziniSEZhaoCDysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNSGenes Dev200923131571158519515974
- ShimizuTKagawaTWadaTMuroyamaYTakadaSIkenakaKWnt signaling controls the timing of oligodendrocyte development in the spinal cordDev Biol2005282239741015950605
- GaesserJMFyffe-MaricichSLIntracellular signaling pathway regulation of myelination and remyelination in the CNSExp Neurol Epub201635
- HanafyKASloaneJARegulation of remyelination in multiple sclerosisFEBS Lett2011585233821382821443876
- YeFChenYHoangTHDAC1 and HDAC2 regulate oligodendrocyte differentiation by disrupting the β-catenin-TCF interactionNat Neurosci200912782983819503085
- SwaffordDManicassamySWnt signaling in dendritic cells: its role in regulation of immunity and toleranceDiscov Med20151910530331025977193
- Zorzella-PezaventoSFChiuso-MinicucciFFrancaTGPersistent inflammation in the CNS during chronic EAE despite local absence of IL-17 productionMediators Inflamm2013201351962723970813
- GeiselJBrückJGlocovaISulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cellsJ Immunol201419283530353924639357
- LiBCuiWLiuJSulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in miceExp Neurol201325023924924120440
- van LoosdregtJFleskensVTiemessenMMCanonical Wnt signaling negatively modulates regulatory T cell functionImmunity201339229831023954131
- StaalFJLuisTCTiemessenMMWnt signalling in the immune system: Wnt is spreading its wingsNat Rev Immunol20088858159318617885
- DrewPDXuJRackeMKPPAR-γ: therapeutic potential for multiple sclerosisPPAR Res2008200862746318604287
- KaundalRKSharmaSSPeroxisome proliferator-activated receptor γ agonists as neuroprotective agentsDrug News Perspect201023424125620520853
- MrakRELandrethGEPPARγ, neuroinflammation, and diseaseJ Neuroinflammation200411515285797
- ErnstIMPalaniKEsatbeyogluTSchwarzKRimbachGSynthesis and Nrf2-inducing activity of the isothiocyanates iberverin, iberin and cheirolinPharmacol Res201370115516223403058
- RadaPRojoAIEvrard-TodeschiNStructural and functional characterization of Nrf2 degradation by the glycogen synthase kinase 3/β-TrCP axisMol Cell Biol201232173486349922751928
- ShangGTangXGaoPSulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 β/Fyn/Nrf2 signaling pathwayJ Nutr Biochem201526659660625724107
- RojoAIRadaPEgeaJRosaAOLopezMGCuadradoAFunctional interference between glycogen synthase kinase-3 β and the transcription factor Nrf2 in protection against kainate-induced hippocampal cell deathMol Cell Neurosci200839112513218619545